242 related articles for article (PubMed ID: 29890894)
1. Stereotactic Body Radiotherapy Treatment for Recurrent, Previously Irradiated Head and Neck Cancer.
Stanisce L; Koshkareva Y; Xu Q; Patel A; Squillante C; Ahmad N; Rajagopalan K; Kubicek GJ
Technol Cancer Res Treat; 2018 Jan; 17():1533033818780086. PubMed ID: 29890894
[TBL] [Abstract][Full Text] [Related]
2. Salvage reirradiaton with stereotactic body radiotherapy for locally recurrent head-and-neck tumors.
Cengiz M; Özyiğit G; Yazici G; Doğan A; Yildiz F; Zorlu F; Gürkaynak M; Gullu IH; Hosal S; Akyol F
Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):104-9. PubMed ID: 20675075
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant stereotactic body radiotherapy±cetuximab following salvage surgery in previously irradiated head and neck cancer.
Vargo JA; Kubicek GJ; Ferris RL; Duvvuri U; Johnson JT; Ohr J; Clump DA; Burton S; Heron DE
Laryngoscope; 2014 Jul; 124(7):1579-84. PubMed ID: 24123056
[TBL] [Abstract][Full Text] [Related]
4. Risk of Severe Toxicity According to Site of Recurrence in Patients Treated With Stereotactic Body Radiation Therapy for Recurrent Head and Neck Cancer.
Ling DC; Vargo JA; Ferris RL; Ohr J; Clump DA; Yau WW; Duvvuri U; Kim S; Johnson JT; Bauman JE; Branstetter BF; Heron DE
Int J Radiat Oncol Biol Phys; 2016 Jul; 95(3):973-980. PubMed ID: 27302512
[TBL] [Abstract][Full Text] [Related]
5. The impact of tumor volume and radiotherapy dose on outcome in previously irradiated recurrent squamous cell carcinoma of the head and neck treated with stereotactic body radiation therapy.
Rwigema JC; Heron DE; Ferris RL; Andrade RS; Gibson MK; Yang Y; Ozhasoglu C; Argiris AE; Grandis JR; Burton SA
Am J Clin Oncol; 2011 Aug; 34(4):372-9. PubMed ID: 20859194
[TBL] [Abstract][Full Text] [Related]
6. Validation of nomogram-based prediction of survival probability after salvage re-irradiation of head and neck cancer.
Shikama N; Kumazaki Y; Tsukamoto N; Ebara T; Makino S; Abe T; Nakahira M; Sugasawa M; Kato S
Jpn J Clin Oncol; 2013 Feb; 43(2):154-60. PubMed ID: 23242582
[TBL] [Abstract][Full Text] [Related]
7. Salvage prostate re-irradiation using high-dose-rate brachytherapy or focal stereotactic body radiotherapy for local recurrence after definitive radiation therapy.
Mbeutcha A; Chauveinc L; Bondiau PY; Chand ME; Durand M; Chevallier D; Amiel J; Kee DL; Hannoun-Lévi JM
Radiat Oncol; 2017 Mar; 12(1):49. PubMed ID: 28274241
[TBL] [Abstract][Full Text] [Related]
8. Salvage stereotactic re-irradiation with CyberKnife for locally recurrent head and neck cancer: a single center experience.
Bonomo P; Cipressi S; Iermano C; Bonucci I; Masi L; Doro R; Favuzza V; Paiar F; Simontacchi G; Meattini I; Greto D; Agresti B; Livi L; Biti G
Tumori; 2014; 100(3):278-83. PubMed ID: 25076238
[TBL] [Abstract][Full Text] [Related]
9. A prospective phase 2 trial of reirradiation with stereotactic body radiation therapy plus cetuximab in patients with previously irradiated recurrent squamous cell carcinoma of the head and neck.
Vargo JA; Ferris RL; Ohr J; Clump DA; Davis KS; Duvvuri U; Kim S; Johnson JT; Bauman JE; Gibson MK; Branstetter BF; Heron DE
Int J Radiat Oncol Biol Phys; 2015 Mar; 91(3):480-8. PubMed ID: 25680594
[TBL] [Abstract][Full Text] [Related]
10. Predictive value of skin invasion in recurrent head and neck cancer patients treated by hypofractionated stereotactic re-irradiation using a cyberknife.
Yamazaki H; Ogita M; Himei K; Nakamura S; Suzuki G; Kotsuma T; Yoshida K; Yoshioka Y
Radiat Oncol; 2015 Oct; 10():210. PubMed ID: 26471020
[TBL] [Abstract][Full Text] [Related]
11. Intensity-modulated radiotherapy with concurrent chemotherapy for previously irradiated, recurrent head and neck cancer.
Biagioli MC; Harvey M; Roman E; Raez LE; Wolfson AH; Mutyala S; Han HS; Markoe A
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1067-73. PubMed ID: 17967302
[TBL] [Abstract][Full Text] [Related]
12. Concurrent cetuximab with stereotactic body radiotherapy for recurrent squamous cell carcinoma of the head and neck: a single institution matched case-control study.
Heron DE; Rwigema JC; Gibson MK; Burton SA; Quinn AE; Ferris RL
Am J Clin Oncol; 2011 Apr; 34(2):165-72. PubMed ID: 20686406
[TBL] [Abstract][Full Text] [Related]
13. Examining tumor control and toxicity after stereotactic body radiotherapy in locally recurrent previously irradiated head and neck cancers: implications of treatment duration and tumor volume.
Vargo JA; Heron DE; Ferris RL; Rwigema JC; Kalash R; Wegner RE; Ohr J; Burton S
Head Neck; 2014 Sep; 36(9):1349-55. PubMed ID: 24038398
[TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of hypofractionated stereotactic body reirradiation in head and neck cancer: Long-term follow-up of a large series.
Kress MA; Sen N; Unger KR; Lominska CE; Deeken JF; Davidson BJ; Newkirk KA; Hwang J; Harter KW
Head Neck; 2015 Oct; 37(10):1403-9. PubMed ID: 24824359
[TBL] [Abstract][Full Text] [Related]
15. Fractionated stereotactic body radiation therapy in the treatment of previously-irradiated recurrent head and neck carcinoma: updated report of the University of Pittsburgh experience.
Rwigema JC; Heron DE; Ferris RL; Gibson M; Quinn A; Yang Y; Ozhasoglu C; Burton S
Am J Clin Oncol; 2010 Jun; 33(3):286-93. PubMed ID: 19875950
[TBL] [Abstract][Full Text] [Related]
16. Stereotactic Body Radiation Therapy as Salvage for Intrathoracic Recurrence in Patients With Previously Irradiated Locally Advanced Non-Small Cell Lung Cancer.
Parks J; Kloecker G; Woo S; Dunlap NE
Am J Clin Oncol; 2016 Apr; 39(2):147-53. PubMed ID: 24457534
[TBL] [Abstract][Full Text] [Related]
17. Benefit of salvage total pharyngolaryngoesophagectomy for recurrent locally advanced head and neck cancer after radiotherapy.
Liu J; Zhang Y; Li Z; Liu S; Li H; Xu Z
Radiat Oncol; 2017 Oct; 12(1):164. PubMed ID: 29073917
[TBL] [Abstract][Full Text] [Related]
18. Reirradiation for recurrent head and neck cancer.
Patel PR; Salama JK
Expert Rev Anticancer Ther; 2012 Sep; 12(9):1177-89. PubMed ID: 23098118
[TBL] [Abstract][Full Text] [Related]
19. Reirradiation using robotic image-guided stereotactic radiotherapy of recurrent head and neck cancer.
Yamazaki H; Ogita M; Himei K; Nakamura S; Suzuki G; Yoshida K; Kotsuma T; Yoshioka Y
J Radiat Res; 2016 Jun; 57(3):288-93. PubMed ID: 26983982
[TBL] [Abstract][Full Text] [Related]
20. Salvage stereotactic reirradiation with or without cetuximab for locally recurrent head-and-neck cancer: a feasibility study.
Comet B; Kramar A; Faivre-Pierret M; Dewas S; Coche-Dequeant B; Degardin M; Lefebvre JL; Lacornerie T; Lartigau EF
Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):203-9. PubMed ID: 22331006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
